EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Microwell Array Embedded Microfluidic Gradient Platform for Drug Screening on Tumor Spheroids

Ling Liu iD, Guoying Wang iD, Ming Li iD

Small · 2026

DOI: 10.1002/smll.202514775 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2026. Verfasst von Ling Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Engineering, Macquarie University, Sydney, NSW, Australia. Hauptthemen laut MEDLINE: Spheroids, Cellular, Microfluidics, Microfluidic Analytical Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council (ARC) Discovery Projects, Cancer Institute NSW (CINSW) fellowship,, National Health and Medical Research Council (NHMRC) Emerging Leadership Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microfluidic gradient platforms, especially flow‐based types, have emerged as promising tools in 3D tumor spheroid research, as they enable precise control of concentration gradients with rapid establishment and sustained long‐term stability. However, current flow‐based gradient chips are often constrained by limited spheroid culture capacity, restricting their utility for large‐scale drug evaluation. Here, we developed a microfluidic gradient platform embedded with high‐density microwell arrays (MEG platform), which enables high‐throughput and physiologically relevant spheroid culture across multiple chambers on a single chip. The total number of spheroids is flexibly tuned by adjusting the microwell array sheet size, and both monoculture and co‐culture spheroids maintain continuous and stable growth with well‐defined morphology. The platform demonstrates stable gradient delivery under dynamic perfusion. It is further applied to assess drug responses in monoculture and co‐culture spheroids, with co‐cultures exhibiting enhanced resistance compared with monocultures. The high‐throughput MEG platform should facilitate the use of tumor spheroid models in large‐scale drug testing and tumor‐stromal interaction studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spheroids, CellularMicrofluidicsMicrofluidic Analytical TechniquesHumansCoculture TechniquesCell Line, TumorDrug Screening Assays, AntitumorDrug Evaluation, Preclinical

Stichwörter der Autor:innen

co‐culture spheroidhigh‐throughput drug evaluationmicrofluidic gradient platformsmicrowelltumor spheroid

Autor:innen und Institutionen

  • School of Engineering, Macquarie University, Sydney, NSW, Australia.
  • School of Mechanical and Manufacturing Engineering, The University of New South Wales, Sydney, NSW, Australia.
  • Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.

ORCID-Profile: Ling Liu, Guoying Wang, Ming Li

Förderung

  • Australian Research Council (ARC) Discovery Projects
  • Cancer Institute NSW (CINSW) fellowship,
  • National Health and Medical Research Council (NHMRC) Emerging Leadership Fellowship

Zitieren

APA

Liu, L., Wang, G., & Li, M. (2026). A Microwell Array Embedded Microfluidic Gradient Platform for Drug Screening on Tumor Spheroids. Small. https://doi.org/10.1002/smll.202514775

Vancouver

Liu L, Wang G, Li M. A Microwell Array Embedded Microfluidic Gradient Platform for Drug Screening on Tumor Spheroids. Small. 2026. doi:10.1002/smll.202514775

BibTeX
@article{Liu2026,
  author = {Liu, Ling and Wang, Guoying and Li, Ming},
  title = {A Microwell Array Embedded Microfluidic Gradient Platform for Drug Screening on Tumor Spheroids},
  journal = {Small},
  year = {2026},
  doi = {10.1002/smll.202514775}
}
Kostenlos starten →